Header

UZH-Logo

Maintenance Infos

Browse by Creators

Navigate back| Up a level
Export as
Number of items: 6.

Meyer, H A; Tölle, A; Jung, M; Fritzsche, F R; Haendler, B; Kristiansen, I; Gaspert, A; Johannsen, M; Jung, K; Kristiansen, G (2009). Identification of stanniocalcin 2 as prognostic marker in renal cell carcinoma. European Urology, 55(3):669-678.

Gutwein, P; Schramme, A; Sinke, N; Abdel-Bakky, M S; Voss, B; Obermüller, N; Doberstein, K; Koziolek, M; Fritzsche, F; Johannsen, M; Jung, K; Schaider, H; Altevogt, P; Ludwig, A; Pfeilschifter, J; Kristiansen, G (2009). Tumoural CXCL16 expression is a novel prognostic marker of longer survival times in renal cell cancer patients. European Journal of Cancer, 45(3):478-489.

Tölle, A; Jung, M; Lein, M; Johannsen, M; Miller, K; Moch, H; Jung, K; Kristiansen, G (2009). Brain-type and liver-type fatty acid-binding proteins: new tumor markers for renal cancer? BMC Cancer, 9:248.

Kempkensteffen, C; Fritzsche, F R; Johannsen, M; Weikert, S; Hinz, S; Dietel, M; Riener, M O; Moch, H; Jung, K; Krause, H; Miller, K; Kristiansen, G (2009). Down-regulation of the pro-apoptotic XIAP associated factor-1 (XAF1) during progression of clear-cell renal cancer. BMC Cancer, 9:276.

Fritzsche, F R; Wassermann, K; Jung, M; Tölle, A; Kristiansen, I; Lein, M; Johannsen, M; Dietel, M; Jung, K; Kristiansen, G (2008). ADAM9 is highly expressed in renal cell cancer and is associated with tumour progression. BMC Cancer, 8:179.

Fritzsche, F R; Oelrich, B; Johannsen, M; Kristiansen, I; Moch, H; Jung, K; Kristiansen, G (2008). Claudin-1 protein expression is a prognostic marker of patient survival in renal cell carcinomas. Clinical Cancer Research, 14(21):7035-7042.

This list was generated on Fri Nov 24 17:23:40 2017 CET.